{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":38,"description":"For participants assigned to the study arm, the surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":38,"seriousNumAffected":2,"seriousNumAtRisk":38,"title":"Parathyroid Eye (PTeye)"},{"deathsNumAffected":0,"deathsNumAtRisk":41,"description":"The surgeon will proceed with the parathyroid surgery as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations.","id":"EG001","otherNumAffected":0,"otherNumAtRisk":41,"seriousNumAffected":5,"seriousNumAtRisk":41,"title":"Usual Standard of Care"}],"frequencyThreshold":"5","seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":38,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":41,"numEvents":0}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Ovarian cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":38,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":41,"numEvents":0}],"term":"Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":38,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":41,"numEvents":1}],"term":"Fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":38,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":41,"numEvents":1}],"term":"Pericardial effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":38,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":41,"numEvents":1}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Myoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":38,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":41,"numEvents":1}],"term":"Neoplasms benign, malignant and unspecified (incl cysts and polyps), Other - specify"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Benign hemangioma and benign angiolipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":38,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":41,"numEvents":1}],"term":"Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify"}],"timeFrame":"Up to 6 months"}